XFLH Capital signs non-binding letter of intent with Renogen Biolab
XFLH Capital Corporation announced it has signed a non-binding letter of intent for a potential business combination with Renogen Biolab Inc.
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- XFLH Capital Corporation, a publicly traded special purpose acquisition company (the "Company"), said it has signed a non-binding letter of intent for a business combination with Renogen Biolab Inc., a Canadian corporation.